Literature DB >> 15814300

Expression of NOX-I, gp91phox, p47phox and P67phox in the aorta segments above and below coarctation.

N D Vaziri1, Z Ni.   

Abstract

Aorta coarctation results in hypertension (HTN) in the arterial tree proximal to stenosis and, as such, provides an ideal model to discern the effects of different levels of blood pressure on the vascular tissue in the same animal. Compelling evidence has emerged supporting the role of oxidative stress as a cause of HTN. However, whether or not HTN (independent of the circulating humoral factors) can cause oxidative stress is less certain. NAD(P)H oxidase isoforms are the main source of reactive oxygen species (ROS) in the vascular tissues. We therefore compared the expressions of NOX-I, gp91phox and the regulatory subunits of the enzyme in the aorta segments residing above and below coarctation in rats with abdominal aorta banding. Rats were studied 4 weeks after aorta banding above the renal arteries or sham operation. Subunits of NAD(P)H oxidase and its NOX-I isoform as well as endothelial NO synthase (eNOS) and nitrotyrosine (footprint of NO oxidation by superoxide) were measured in the aorta segments above and below coarctation. The gp91phox, p47phox, and p67phox subunits of NAD(P)H oxidase, NOX-I isoform, eNOS and nitrotyrosine were markedly increased in the aorta segment above coarctation (hypertensive zone), but were virtually unchanged in the segment below coarctation. Since, excepting blood pressure, all other conditions were constant, the upregulation of NAD(P)H oxidase isoforms and the increased NO oxidation in the aorta segment above, but not below, coarctation prove that HTN, per se, independent of circulating mediators can cause oxidative/nitrosative stress in the arterial wall. These observations suggest that HTN control may represent a specific form of antioxidant therapy for hypertensive disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814300     DOI: 10.1016/j.bbagen.2005.03.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  A coupled experimental and computational approach to quantify deleterious hemodynamics, vascular alterations, and mechanisms of long-term morbidity in response to aortic coarctation.

Authors:  Arjun Menon; David C Wendell; Hongfeng Wang; Thomas J Eddinger; Jeffrey M Toth; Ronak J Dholakia; Paul M Larsen; Eric S Jensen; John F Ladisa
Journal:  J Pharmacol Toxicol Methods       Date:  2011-11-04       Impact factor: 1.950

2.  Altered hemodynamics, endothelial function, and protein expression occur with aortic coarctation and persist after repair.

Authors:  Arjun Menon; Thomas J Eddinger; Hongfeng Wang; David C Wendell; Jeffrey M Toth; John F LaDisa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-09-28       Impact factor: 4.733

Review 3.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

4.  Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats.

Authors:  Y Alvarez; A M Briones; R Hernanz; J V Pérez-Girón; M J Alonso; M Salaices
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

Review 5.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

Review 6.  Nox family NADPH oxidases in mechano-transduction: mechanisms and consequences.

Authors:  Ralf P Brandes; Norbert Weissmann; Katrin Schröder
Journal:  Antioxid Redox Signal       Date:  2013-07-05       Impact factor: 8.401

7.  Salt-sensitive hypertension in mitochondrial superoxide dismutase deficiency is associated with intra-renal oxidative stress and inflammation.

Authors:  Kyubok Jin; Nosratola D Vaziri
Journal:  Clin Exp Nephrol       Date:  2013-08-10       Impact factor: 2.801

Review 8.  Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease.

Authors:  Stacey Ruiz; Pablo E Pergola; Richard A Zager; Nosratola D Vaziri
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.